Skip to content

Exercise-induced High-sensitivity Troponin Levels as a Predictor for Obstructive Coronary Artery Disease

Exercise-induced High-sensitivity Troponin Levels as a Predictor for Obstructive Coronary Artery Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02626806
Acronym
EUROCAD
Enrollment
150
Registered
2015-12-10
Start date
2013-11-30
Completion date
Unknown
Last updated
2015-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

exercise test, HS -troponin, Coronary artery disease

Brief summary

1. To compare hs-TnT levels after a cardiac stress test in patients with vs. patients without CAD 2. To assess the level of post-exercise hs-TnT predicting CAD (using ROC-analysis) 3. To determine the sensitivity, specificity and accuracy of this exercise-induced hsTopT level in predicting CAD, either alone or in relation to traditional patient-related and exercise test-related metrics

Interventions

None listed

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with suspected CAD, planned for diagnostic coronary angiogram 2. Patients with previous revascularization, suspected of recurrent ischemia

Exclusion criteria

1. Congestive cardiomyopathy with LV EF \< 35% 2. Renal failure with eGFR \< 30 ml/min 3. Known structural or severe valvular heart disease 4. Prior CABG 5. Previous ACS \< 6 weeks 6. Known incomplete revascularization after previous PCI 7. Unstable angina or ACS (defined as unstable anginal symptoms + ECG changes or hs-TnT \> 0.053 ng/L)

Design outcomes

Primary

MeasureTime frame
Presence of coronary artery stenosis more than 50%24 hours

Countries

Belgium

Contacts

Primary ContactDries De Cock, MD
dries.decock@uzleuven.be003216341519
Backup ContactNick Hiltrop, MD
nick.hiltrop@uzleuven.be003216344235

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026